Bladder cancer natural history, complications and prognosis
|
Bladder cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bladder cancer natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Bladder cancer natural history, complications and prognosis |
|
FDA on Bladder cancer natural history, complications and prognosis |
|
CDC on Bladder cancer natural history, complications and prognosis |
|
Bladder cancer natural history, complications and prognosis in the news |
|
Blogs on Bladder cancer natural history, complications and prognosis |
|
Risk calculators and risk factors for Bladder cancer natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Between 2004 and 2010, the 5-year relative survival of patients with bladder cancer was 79.1%.[1]
Prognosis
5-Year Survival
- Between 2004 and 2010, the 5-year relative survival of patients with bladder cancer was 79.1%.[1]
- When stratified by age, the 5-year relative survival of patients with bladder cancer was 83.8% and 74.1% for patients <65 and ≥ 65 years of age respectively.[1]
- The survival of patients with bladder cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of bladder cancer:[1]
| Stage | 5-year relative survival (%), (2004-2010) |
| All stages | 77.4% |
| In situ | 96.2% |
| Localized | 69.2% |
| Regional | 33.7% |
| Distant | 5.5% |
| Unstaged | 48.7% |
- Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 2004 and 2010 of bladder cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.